Hewitt, Richard J.
Maher, Toby M. http://orcid.org/0000-0001-7192-9149
Article History
First Online: 12 March 2019
Compliance with Ethical Standards
:
: Richard J. Hewitt has no conflicts of interest. Toby M. Maher has, via his institution, received industry-academic funding from GlaxoSmithKline R&D and UCB, and has received consultancy or speakers’ fees from Apellis, AstraZeneca, Bayer, Biogen Idec, Boehringer Ingelheim, Galapagos, GlaxoSmithKline R&D, Indalo, Pliant, ProMetic, Roche, Samumed and UCB.